Trial Profile
A 6-month study to evaluate deferiprone therapy in patients with mild neutropenia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Neutropenia; Thalassaemia
- Focus Therapeutic Use
- 08 Dec 2015 New trial record